Gaetano Gioffrè

ORCID: 0000-0001-8601-3766
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiovascular and Diving-Related Complications
  • Vascular Procedures and Complications
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Cardiac Valve Diseases and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Peripheral Artery Disease Management
  • Congenital Heart Disease Studies
  • Central Venous Catheters and Hemodialysis
  • Cardiac pacing and defibrillation studies
  • Atrial Fibrillation Management and Outcomes
  • Trauma Management and Diagnosis
  • Restraint-Related Deaths
  • Vascular anomalies and interventions
  • Pain Management and Treatment
  • Airway Management and Intubation Techniques
  • Aortic Disease and Treatment Approaches
  • Coronary Artery Anomalies
  • COVID-19 Clinical Research Studies
  • Neuroscience of respiration and sleep
  • Advanced MRI Techniques and Applications

St. Eugenio Hospital
2011-2021

Sapienza University of Rome
2012

San Raffaele University of Rome
2008

Istituti di Ricovero e Cura a Carattere Scientifico
2008

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2008

European Hospital
1993-1995

<h3>Objective:</h3> To obtain a "snapshot" view of access-specific percutaneous cardiovascular procedures outcomes in the real world. <h3>Design:</h3> Multicentre, prospective study performed over 30-day period. <h3>Setting:</h3> Nine hospitals with invasive cardiology facilities, reflecting contemporary state healthcare. <h3>Patients:</h3> Unselected consecutive sample patients undergoing any procedure requiring an arterial access. <h3>Interventions:</h3> Percutaneous by radial or femoral...

10.1136/hrt.2008.150714 article EN Heart 2008-11-26

It is still controversial whether sirolimus-eluting stent (SES) and paclitaxel-eluting (PES) are equally effective in patients with diabetes. In these patients, multiple individual variables may be responsible for neointimal hyperplasia, thus making difficult the comparison of two drug-eluting stents (DES).We designed a prospective, randomized study to compare efficacy prevention restenosis SES PES, both implanted same diabetic patient de novo coronary artery lesions undergoing elective...

10.2337/dc07-1377 article EN Diabetes Care 2007-12-28

Objectives To evaluate the feasibility and safety of percutaneous closure complex secundum‐type atrial septal defects (ASD) in patients with posterior‐inferior rim deficiency. Background Transcatheter approach is method choice for ASD closure; however, up to now 20% are not considered suitable intervention because lack surrounding rims, especially posterior‐inferior. Methods A total 268 were evaluated between March 2005 April 2011 closure. Twenty‐four (9%) a referred surgery due inadequate...

10.1002/ccd.24633 article EN Catheterization and Cardiovascular Interventions 2012-08-25

Polymer-free biolimus-eluting stents (PF-BES) have been shown to be superior bare metal in high bleeding risk (HBR) patients treated with one-month dual antiplatelet therapy (DAPT). However, limited evidence is available on PF-BES non-HBR patients. We aimed evaluate the safety and efficacy of all-comer undergoing percutaneous coronary intervention (PCI).Patients stable artery disease or acute syndromes (ACS) PCI routine clinical practice were included a multicentre, prospective registry....

10.4244/eij-d-18-00148 article EN EuroIntervention 2018-09-01

The aim of this observational study was to compare acute and 12-month results percutaneous closure patent foramen ovale (PFO) with two occluder devices.Between June 2007 October 2014, 406 consecutive patients (48.1±13.3 years, 243 women) underwent PFO either the AMPLATZER (n=179) or Figulla (n=227) device after a stroke transient ischaemic attack ascribed PFO. A right-to-left shunt grade >1 previously detected in all atrial septal aneurysm present 111 (27.5%) patients. Patients were followed...

10.4244/eij-d-15-00499 article EN EuroIntervention 2017-04-01

Abstract Despite technological evolution, percutaneous coronary interventions targeting calcifications remain challenging and associated with high rates of complications adverse outcomes. Over the years, rotational atherectomy has emerged as reference treatment calcified artery lesions despite some inherent limitations. Also, typically requires relatively large guiding catheters which may unfavorably impact on decision for transradial access, especially when radial is small, consequently...

10.1002/ccd.28296 article EN Catheterization and Cardiovascular Interventions 2019-04-19

Abstract Objectives This study aimed at assessing the performance of a new generation polymer‐free biolimus‐eluting stent (BES) in real‐world patients with ST‐segment elevation myocardial infarction (STEMI). Background Polymers components early‐generation drug‐eluting stents have been implicated pathogenesis delayed arterial healing, vessel remodeling, and thrombosis. Recently, novel BES has shown excellent clinical trial setting. Methods Overall, 175 consecutive (64 ± 14 years, 141 men)...

10.1002/ccd.27206 article EN Catheterization and Cardiovascular Interventions 2017-08-02

We present the complex case of a high-risk patient with nonvalvular atrial fibrillation, who experienced non-ST elevation myocardial infarction complicated by left ventricular (LV) thrombi and underwent percutaneous coronary intervention drug-eluting stent implantation. The was initially treated short-term triple therapy including aspirin, clopidogrel, rivaroxaban 15 mg/die. Following aspirin dropping one month after discharge, continued on dual clopidogrel rivaroxaban, clinical imaging...

10.1155/2018/6503435 article EN cc-by Case Reports in Cardiology 2018-01-01

Gaspardone, Achille; Giardina, Arianna; Gioffrè, Gaetano; Iamele, Maria; Borioni, Raoul Author Information

10.2459/jcm.0b013e32833db0b2 article EN Journal of Cardiovascular Medicine 2011-03-08
Coming Soon ...